| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Acknowledgement to Referees
|
|
|
|
|
1 |
p. 1-3
|
artikel
|
| 2 |
Acknowledgement to Referees
|
|
|
|
|
1 |
p. 1-3
|
artikel
|
| 3 |
Acknowledgement to Referees
|
|
|
|
|
1 |
p. 1-3
|
artikel
|
| 4 |
Acknowledgement to Referees
|
|
|
|
|
1 |
p. 1-3
|
artikel
|
| 5 |
A Cost-Utility Analysis of Prostate Cancer Screening in Australia
|
Keller, Andrew
|
|
2016
|
|
1 |
p. 95-111
|
artikel
|
| 6 |
A Critical Systematic Review of Budget Impact Analyses on Drugs in the EU Countries
|
Vooren, Katelijne van de
|
|
2013
|
|
1 |
p. 33-40
|
artikel
|
| 7 |
Affordability of medicines and patients’ cost-reducing behaviour
|
Atella, Vincenzo
|
|
2005
|
|
1 |
p. 23-35
|
artikel
|
| 8 |
Alcohol policy and taxation in South Africa
|
Ataguba, John Ele-Ojo
|
|
2012
|
|
1 |
p. 65-76
|
artikel
|
| 9 |
A macroeconomic approach to evaluating policies to contain antimicrobial resistance
|
Smith, Richard D.
|
|
2006
|
|
1 |
p. 55-65
|
artikel
|
| 10 |
A Multinational European Study of Patient Preferences for Novel Diagnostics to Manage Antimicrobial Resistance
|
Mott, David J.
|
|
|
|
1 |
p. 69-79
|
artikel
|
| 11 |
An alternative approach to resource allocation
|
Mooney, Gavin
|
|
2004
|
|
1 |
p. 29-33
|
artikel
|
| 12 |
Analytical strategies for characterizing chemotherapy diffusion with patient-level population-based data
|
Sima, Cami S.
|
|
2010
|
|
1 |
p. 37-51
|
artikel
|
| 13 |
A New Reimbursement System for Innovative Pharmaceuticals Combining Value-Based and Free Market Pricing
|
Godman, Brian
|
|
2013
|
|
1 |
p. 79-82
|
artikel
|
| 14 |
Approaches to Measure Efficiency in Primary Care: A Systematic Literature Review
|
Neri, Margherita
|
|
|
|
1 |
p. 19-33
|
artikel
|
| 15 |
‘Appropriateness’ in Italy: A ‘Magic Word’ in Pharmaceuticals?
|
Garattini, Livio
|
|
2016
|
|
1 |
p. 1-3
|
artikel
|
| 16 |
A Review of the Economic Tools for Assessing New Medical Devices
|
Craig, Joyce A.
|
|
2014
|
|
1 |
p. 15-27
|
artikel
|
| 17 |
Assessing the Cost Utility of Response-Guided Therapy in Patients with Chronic Hepatitis C Genotype 1 in the UK Using the MONARCH Model
|
McEwan, Phil
|
|
2012
|
|
1 |
p. 53-63
|
artikel
|
| 18 |
Assessing the Effect of Potential Reductions in Non-Hepatic Mortality on the Estimated Cost-Effectiveness of Hepatitis C Treatment in Early Stages of Liver Disease
|
Leidner, Andrew J.
|
|
2016
|
|
1 |
p. 65-74
|
artikel
|
| 19 |
Association Between Medicare’s Mandatory Hospital Value-Based Purchasing Program and Cost Inefficiency
|
Izón, Germán M.
|
|
2017
|
|
1 |
p. 79-90
|
artikel
|
| 20 |
A Systematic Review of Cost-Effectiveness Analyses of Left Ventricular Assist Devices: Issues and Challenges
|
Schmier, Jordana K.
|
|
2018
|
|
1 |
p. 35-46
|
artikel
|
| 21 |
A Systematic Review of Cost-of-Illness Studies of Multimorbidity
|
Wang, Lili
|
|
2017
|
|
1 |
p. 15-29
|
artikel
|
| 22 |
A Systematic Review of Economic Evaluations in Second and Later Lines of Therapy for the Treatment of Non-Small Cell Lung Cancer
|
Jäkel, Anne
|
|
2012
|
|
1 |
p. 27-43
|
artikel
|
| 23 |
A Systematic Review of Health Economic Evaluations of Diagnostic Biomarkers
|
Oosterhoff, Marije
|
|
2015
|
|
1 |
p. 51-65
|
artikel
|
| 24 |
A Systematic Review of Kidney Transplantation Decision Modelling Studies
|
Yaghoubi, Mohsen
|
|
|
|
1 |
p. 39-51
|
artikel
|
| 25 |
A Systematic Review of the World’s Largest Government Sponsored Health Insurance Scheme for 500 Million Beneficiaries in India: Pradhan Mantri Jan Arogya Yojana
|
Aashima,
|
|
|
|
1 |
p. 17-32
|
artikel
|
| 26 |
A tribute to the life and work of Bernie O’Brien
|
Bridges, John F. P.
|
|
2004
|
|
1 |
p. 57-60
|
artikel
|
| 27 |
A tribute to the life and work of Bernie O’Brien
|
Bridges, John F. P.
|
|
|
|
1 |
p. 57-60
|
artikel
|
| 28 |
Authors’ Reply to Angelis and Kanavos: “Does MCDA Trump CEA?”
|
Campillo-Artero, Carlos
|
|
2018
|
|
1 |
p. 125
|
artikel
|
| 29 |
Authors’ Reply to Gandjour: “10 Years of AMNOG: What is the Willingness-to-Pay for Pharmaceuticals in Germany?”
|
Büssgen, Melanie
|
|
|
|
1 |
p. 127-128
|
artikel
|
| 30 |
Authors’ Reply to Godman and Gustafsson: “A New Reimbursement System for Innovative Pharmaceuticals Combining Value-Based and Free Market Pricing”
|
Persson, Ulf
|
|
2013
|
|
1 |
p. 83-84
|
artikel
|
| 31 |
Availability and Variability of Consumer Prices for Lumbar Discectomy Across US Hospitals in 2018
|
Butler, Alexander J.
|
|
|
|
1 |
p. 81-96
|
artikel
|
| 32 |
Avoiding Opportunity Cost Neglect in Cost-Effectiveness Analysis for Health Technology Assessment
|
Lomas, James
|
|
|
|
1 |
p. 13-18
|
artikel
|
| 33 |
A wolf dressed in sheep’s clothing
|
Bridges, John F. P.
|
|
2005
|
|
1 |
p. 55-64
|
artikel
|
| 34 |
Biosimilar Versus Patented Erythropoietins: Learning from 5 Years of European and Japanese Experience
|
Bocquet, François
|
|
2014
|
|
1 |
p. 47-59
|
artikel
|
| 35 |
Budget Impact Analysis of a Renal Point-of-Care Test in Dutch Community Pharmacies to Prevent Antibiotic-Related Hospitalizations
|
Gout-Zwart, Judith J.
|
|
2018
|
|
1 |
p. 55-63
|
artikel
|
| 36 |
Budget Impact Analysis of Liposomal Amphotericin B and Amphotericin B Lipid Complex in the Treatment of Invasive Fungal Infections in the United States
|
Yang, Hongbo
|
|
2013
|
|
1 |
p. 85-93
|
artikel
|
| 37 |
Cardiac Resynchronisation Therapy in Patients with Moderate to Severe Heart Failure in Germany: A Cost-Utility Analysis of the Additional Defibrillator
|
Hadwiger, Moritz
|
|
|
|
1 |
p. 57-68
|
artikel
|
| 38 |
Clinical Practice Variation Needs to be Considered in Cost-Effectiveness Analyses: A Case Study of Patients with a Recent Transient Ischemic Attack or Minor Ischemic Stroke
|
Buisman, Leander R.
|
|
2015
|
|
1 |
p. 67-75
|
artikel
|
| 39 |
Comment on: “Cost Effectiveness of Tiotropium in Patients with Asthma Poorly Controlled on Inhaled Glucocorticosteroids and Long-Acting β-Agonists”
|
Samuelsen, Carl
|
|
2015
|
|
1 |
p. 117-118
|
artikel
|
| 40 |
Comment on: “Does MCDA Trump CEA?”
|
Angelis, Aris
|
|
2018
|
|
1 |
p. 123-124
|
artikel
|
| 41 |
Comment on: “The Assessment of Patient-Reported Outcomes for the Authorisation of Medicines in Europe: A Review of European Public Assessment Reports from 2017 to 2022”
|
de Vries, Sieta T.
|
|
|
|
1 |
p. 123-124
|
artikel
|
| 42 |
Comment on: “10 Years of AMNOG: What is the Willingness-to-Pay for Pharmaceuticals in Germany?”
|
Gandjour, Afschin
|
|
|
|
1 |
p. 125-126
|
artikel
|
| 43 |
Comparative Cost-Effectiveness Analysis of Three Different Automated Medication Systems Implemented in a Danish Hospital Setting
|
Risør, Bettina Wulff
|
|
2017
|
|
1 |
p. 91-106
|
artikel
|
| 44 |
Comparing Willingness to Pay for Improved Drinking-Water Quality Using Stated Preference Methods in Rural and Urban Kenya
|
Brouwer, Roy
|
|
2014
|
|
1 |
p. 81-94
|
artikel
|
| 45 |
Comparison of Modes of Administration and Alternative Formats for Eliciting Societal Preferences for Burden of Illness
|
Rowen, Donna
|
|
2015
|
|
1 |
p. 89-104
|
artikel
|
| 46 |
Comparison of Prices and Affordability of Cancer Medicines in 16 Countries in Europe and Latin America
|
Moye-Holz, Daniela
|
|
|
|
1 |
p. 67-77
|
artikel
|
| 47 |
Considering the value associated with innovation in health technology appraisal decisions (deliberations)
|
Green, Colin
|
|
2010
|
|
1 |
p. 1-5
|
artikel
|
| 48 |
Correction to: Cost Effectiveness of Allogeneic Umbilical Cord Blood-Derived Mesenchymal Stem Cells in Patients with Knee Osteoarthritis
|
Suh, Kangho
|
|
|
|
1 |
p. 153
|
artikel
|
| 49 |
Correction to: Dutch Economic Value of Radium-223 in Metastatic Castration-Resistant Prostate Cancer
|
Peters, Michel L.
|
|
2018
|
|
1 |
p. 145
|
artikel
|
| 50 |
Cost-Effectiveness Analysis of Boceprevir for the Treatment of Chronic Hepatitis C Virus Genotype 1 Infection in Portugal
|
Elbasha, Elamin H.
|
|
|
|
1 |
p. 65-78
|
artikel
|
| 51 |
Cost-Effectiveness Analysis of Boceprevir for the Treatment of Chronic Hepatitis C Virus Genotype 1 Infection in Portugal
|
Elbasha, Elamin H.
|
|
2013
|
|
1 |
p. 65-78
|
artikel
|
| 52 |
Cost-Effectiveness Analysis of Clinically Indicated Versus Routine Replacement of Peripheral Intravenous Catheters
|
Tuffaha, Haitham W.
|
|
2014
|
|
1 |
p. 51-58
|
artikel
|
| 53 |
Cost-Effectiveness Analysis of Smoking Cessation Interventions in Japan Using a Discrete-Event Simulation
|
Igarashi, Ataru
|
|
2015
|
|
1 |
p. 77-87
|
artikel
|
| 54 |
Cost-effectiveness analysis of switching antipsychotic medication to long-acting injectable risperidone in patients with schizophrenia
|
Olivares, José M.
|
|
2008
|
|
1 |
p. 41-53
|
artikel
|
| 55 |
Cost-Effectiveness Analysis of the Gonadotropin Treatments HP-hMG and rFSH for Assisted Reproductive Technology in France: A Markov Model Analysis
|
Barriere, Paul
|
|
2017
|
|
1 |
p. 65-77
|
artikel
|
| 56 |
Cost-Effectiveness Assessment of Orphan Drugs
|
Simoens, Steven
|
|
2012
|
|
1 |
p. 1-3
|
artikel
|
| 57 |
Cost Effectiveness of Allogeneic Umbilical Cord Blood-Derived Mesenchymal Stem Cells in Patients with Knee Osteoarthritis
|
Suh, Kangho
|
|
|
|
1 |
p. 141-152
|
artikel
|
| 58 |
Cost Effectiveness of Human Papillomavirus-16/18 Genotyping in Cervical Cancer Screening
|
Huh, Warner K.
|
|
2014
|
|
1 |
p. 95-107
|
artikel
|
| 59 |
Cost effectiveness of implantable cardioverter-defibrillators for primary prevention in a belgian context
|
Neyt, Mattias
|
|
2008
|
|
1 |
p. 67-80
|
artikel
|
| 60 |
Cost Effectiveness of Molecular Diagnostic Testing Algorithms for the Treatment Selection of Frontline Ibrutinib for Patients with Chronic Lymphocytic Leukemia in Australia
|
Vu, Martin
|
|
|
|
1 |
p. 107-122
|
artikel
|
| 61 |
Cost-Effectiveness of Scaling Up Modern Family Planning Interventions in Low- and Middle-Income Countries: An Economic Modeling Analysis in Indonesia and Uganda
|
Zakiyah, Neily
|
|
2018
|
|
1 |
p. 65-76
|
artikel
|
| 62 |
Cost effectiveness of screen-and-treat strategies for low bone mineral density
|
Schousboe, John T.
|
|
2008
|
|
1 |
p. 1-18
|
artikel
|
| 63 |
Cost effectiveness of sirolimus-eluting stents compared with bare metal stents in acute myocardial infarction
|
Canoui-Poitrine, Florence
|
|
2009
|
|
1 |
p. 19-29
|
artikel
|
| 64 |
Cost-Effectiveness of the Second COVID-19 Booster Vaccination in the USA
|
Li, Rui
|
|
|
|
1 |
p. 85-95
|
artikel
|
| 65 |
Cost Effectiveness of Transcatheter Aortic Valve Replacement Compared with Medical Management or Surgery for Patients with Aortic Stenosis
|
Iannaccone, Andrea
|
|
2014
|
|
1 |
p. 29-45
|
artikel
|
| 66 |
Costs and Cost-Effectiveness of User-Testing of Health Professionals’ Guidelines to Reduce the Frequency of Intravenous Medicines Administration Errors by Nurses in the United Kingdom: A Probabilistic Model Based on Voriconazole Administration
|
Jones, Matthew D.
|
|
|
|
1 |
p. 91-104
|
artikel
|
| 67 |
Costs to hospitals of acquiring and processing blood in the US
|
Toner, Richard W.
|
|
2011
|
|
1 |
p. 29-37
|
artikel
|
| 68 |
Cost-Utility Analysis of Dapagliflozin Versus Saxagliptin Treatment as Monotherapy or Combination Therapy as Add-on to Metformin for Treating Type 2 Diabetes Mellitus
|
Hu, Shanshan
|
|
|
|
1 |
p. 69-79
|
artikel
|
| 69 |
Decentralisation strategies and provider incentives in healthcare
|
Mannion, Russell
|
|
2005
|
|
1 |
p. 47-54
|
artikel
|
| 70 |
Delivery of Essential Medicines to Primary Care Institutions and its Association with Procurement Volume and Price: A Case Study in Hubei Province, China
|
Tang, Yuqing
|
|
2016
|
|
1 |
p. 57-64
|
artikel
|
| 71 |
Determinants of COVID-19 Vaccine Rollouts and Their Effects on Health Outcomes
|
Deb, Pragyan
|
|
|
|
1 |
p. 71-89
|
artikel
|
| 72 |
Determinants of out-of-pocket health expenditure in China
|
You, Xuedan
|
|
2011
|
|
1 |
p. 39-49
|
artikel
|
| 73 |
Determining What Represents Value in the Treatment of Refractory or Unexplained Chronic Cough from the Perspective of Key Stakeholders in Spain Using Multi-Criteria Decision Analysis
|
Domingo, Christian
|
|
|
|
1 |
p. 119-130
|
artikel
|
| 74 |
Development of a budget-impact model to quantify potential cost savings from prescription opioids designed to deter abuse or ease of extraction
|
White, Alan G.
|
|
2009
|
|
1 |
p. 61-70
|
artikel
|
| 75 |
Development of a Health Technology Assessment Quality Appraisal Checklist (HTA-QAC) for India
|
Chugh, Yashika
|
|
|
|
1 |
p. 11-22
|
artikel
|
| 76 |
Did we see it Coming? An Evaluation of the Swedish Early Awareness and Alert System
|
Eriksson, Irene
|
|
2018
|
|
1 |
p. 93-101
|
artikel
|
| 77 |
Differences in generic drug prices between the US and Canada
|
Gooi, Malcolm
|
|
2008
|
|
1 |
p. 19-26
|
artikel
|
| 78 |
Direct Costs of Unintended Pregnancy in the Russian Federation
|
Lowin, Julia
|
|
2014
|
|
1 |
p. 61-68
|
artikel
|
| 79 |
Direct economic burden of high-risk and metastatic melanoma in the elderly
|
Davis, Keith L.
|
|
2009
|
|
1 |
p. 31-41
|
artikel
|
| 80 |
Driver perception response time during the signal change interval
|
Goh, Pin-Kai
|
|
2004
|
|
1 |
p. 9-15
|
artikel
|
| 81 |
Dutch Economic Value of Radium-223 in Metastatic Castration-Resistant Prostate Cancer
|
Peters, Michel L.
|
|
2017
|
|
1 |
p. 133-143
|
artikel
|
| 82 |
Economic Burden and Disparities in Healthcare Resource Use Among Adult Patients with Cardiac Arrhythmia
|
Tang, Derek H.
|
|
2013
|
|
1 |
p. 59-71
|
artikel
|
| 83 |
Economic Consequences of Anti-HCV Treatment of Patients Diagnosed Through Screening in Italy: A Prospective Modelling Analysis
|
Marcellusi, Andrea
|
|
|
|
1 |
p. 133-143
|
artikel
|
| 84 |
Economic Crisis, Austerity Policies, Health and Fairness: Lessons Learned in Spain
|
Lopez-Valcarcel, Beatriz G.
|
|
2016
|
|
1 |
p. 13-21
|
artikel
|
| 85 |
Economic Effects of Fixed-Dose Versus Loose-Dose Combination Therapy for Type 2 Diabetes Patients
|
Böhm, Anna-Katharina
|
|
|
|
1 |
p. 109-118
|
artikel
|
| 86 |
Economic Evaluation in Ethiopian Healthcare Sector Decision Making: Perception, Practice and Barriers
|
Zegeye, Elias Asfaw
|
|
2016
|
|
1 |
p. 33-43
|
artikel
|
| 87 |
Economic Evaluation of an Intervention Designed to Reduce Bullying in Australian Schools
|
Jadambaa, Amarzaya
|
|
|
|
1 |
p. 79-89
|
artikel
|
| 88 |
Economic Evaluation of Senshio® (Ospemifene) for the Treatment of Vulvovaginal Atrophy in Scotland
|
Dymond, Amy
|
|
|
|
1 |
p. 123-132
|
artikel
|
| 89 |
Economic Evaluations of Preventive Interventions for Dental Caries and Periodontitis: A Systematic Review
|
Nguyen, Tan Minh
|
|
|
|
1 |
p. 53-70
|
artikel
|
| 90 |
Economic Modelling of Screen-and-Treat Strategies for Brazilian Women at Risk of Hereditary Breast and Ovarian Cancer
|
Simoes Correa-Galendi, Julia
|
|
|
|
1 |
p. 97-109
|
artikel
|
| 91 |
Economic Theory and Medical Assistance in Dying
|
Redelmeier, Donald A.
|
|
|
|
1 |
p. 5-8
|
artikel
|
| 92 |
Editorial foreword
|
Birks, Stuart
|
|
2004
|
|
1 |
p. 1
|
artikel
|
| 93 |
Effect of an Online Reimbursement Application System on Prescribing of Lidocaine 5% Medicated Plaster in the Republic of Ireland
|
Smith, Amelia
|
|
|
|
1 |
p. 133-140
|
artikel
|
| 94 |
Elections have Consequences: Partisan Politics may be Literally Killing Us
|
Maas, Alexander
|
|
|
|
1 |
p. 45-56
|
artikel
|
| 95 |
Erratum to: Cost Effectiveness of Tiotropium in Patients with Asthma Poorly Controlled on Inhaled Glucocorticosteroids and Long-Acting β-Agonists
|
Willson, Jenny
|
|
2016
|
|
1 |
p. 119-125
|
artikel
|
| 96 |
Ethically Acceptable Compensation for Living Donations of Organs, Tissues, and Cells: An Unexploited Potential?
|
Platz, Trine Tornøe
|
|
2018
|
|
1 |
p. 1-14
|
artikel
|
| 97 |
Exploratory Approach to Incorporating Carbon Footprint in Health Technology Assessment (HTA) Modelling: Cost-Effectiveness Analysis of Health Interventions in the United Kingdom
|
Kindred, Max
|
|
|
|
1 |
p. 49-60
|
artikel
|
| 98 |
Exploring the Integration of Environmental Impacts in the Cost Analysis of the Pilot MEL-SELF Trial of Patient-Led Melanoma Surveillance
|
Williams, Jake T. W.
|
|
|
|
1 |
p. 23-30
|
artikel
|
| 99 |
Family Spillover Effects: Are Economic Evaluations Misrepresenting the Value of Healthcare Interventions to Society?
|
Leech, Ashley A.
|
|
|
|
1 |
p. 5-10
|
artikel
|
| 100 |
Financial Incentives in the Path to Recovery from the COVID-19 Pandemic
|
Gandjour, Afschin
|
|
|
|
1 |
p. 5-8
|
artikel
|
| 101 |
Financing Comprehensive Immunization Services in Lao PDR: A Fiscal Space Analysis From a Public Policy Perspective
|
Bahuguna, Pankaj
|
|
|
|
1 |
p. 131-140
|
artikel
|
| 102 |
Genetic health technology and economic evaluation
|
Jarrett, James
|
|
2006
|
|
1 |
p. 27-35
|
artikel
|
| 103 |
Healthcare Costs Associated with Antiretroviral Adherence Among Medicaid Patients
|
Pruitt, Zachary
|
|
2014
|
|
1 |
p. 69-80
|
artikel
|
| 104 |
Healthcare costs in renal transplant recipients using branded versus generic ciclosporin
|
Helderman, J. Harold
|
|
2010
|
|
1 |
p. 61-68
|
artikel
|
| 105 |
Healthcare Finance in the Kingdom of Saudi Arabia: A Qualitative Study of Householders’ Attitudes
|
Al-Hanawi, Mohammed Khaled
|
|
2017
|
|
1 |
p. 55-64
|
artikel
|
| 106 |
Healthcare payment incentives
|
Eggleston, Karen
|
|
2004
|
|
1 |
p. 47-56
|
artikel
|
| 107 |
Health-promoting schools
|
Lee, Albert
|
|
2009
|
|
1 |
p. 11-17
|
artikel
|
| 108 |
Health reform, equity and primary healthcare
|
Thomas, Stephen
|
|
2006
|
|
1 |
p. 1-4
|
artikel
|
| 109 |
Health State Utility Values for Age-Related Macular Degeneration: Review and Advice
|
Butt, Thomas
|
|
2016
|
|
1 |
p. 23-32
|
artikel
|
| 110 |
How Important Is Health Status in Defining Quality of Life for Older People? An Exploratory Study of the Views of Older South Australians
|
Milte, Catherine M.
|
|
2013
|
|
1 |
p. 73-84
|
artikel
|
| 111 |
Impact of demographic changes on healthcare expenditures and funding in the EU
|
Gandjour, Afschin
|
|
2005
|
|
1 |
p. 1-4
|
artikel
|
| 112 |
Improving the Hospital Quality of Care during Winter Periods by Optimizing Budget Allocation Between Rotavirus Vaccination and Bed Expansion
|
Dort, Thibaut
|
|
2017
|
|
1 |
p. 123-132
|
artikel
|
| 113 |
Incremental Cost Effectiveness of Bedaquiline for the Treatment of Rifampicin-Resistant Tuberculosis in South Africa: Model-Based Analysis
|
Schnippel, Kathryn
|
|
2017
|
|
1 |
p. 43-54
|
artikel
|
| 114 |
Indirect and Direct Mapping of the Cancer-Specific EORTC QLQ-C30 onto EQ-5D-5L Utility Scores
|
Meunier, Aurelie
|
|
|
|
1 |
p. 119-131
|
artikel
|
| 115 |
Inflammatory Bowel Diseases (Crohn´s Disease and Ulcerative Colitis): Cost of Treatment in Serbia and the Implications
|
Kostić, Marina
|
|
2016
|
|
1 |
p. 85-93
|
artikel
|
| 116 |
Informing disinvestment through cost-effectiveness modelling
|
Karnon, Jonathan
|
|
2009
|
|
1 |
p. 1-9
|
artikel
|
| 117 |
Inpatient costs of endophthalmitis evaluated for the whole of France
|
Colin, Xavier
|
|
2010
|
|
1 |
p. 53-60
|
artikel
|
| 118 |
Insulin Glargine in a Brazilian State: Should the Government Disinvest? An Assessment Based on a Systematic Review
|
Caires de Souza, Ana Luísa
|
|
2013
|
|
1 |
p. 19-32
|
artikel
|
| 119 |
Intra-operative vs pre-operative endoscopic sphincterotomy in patients with gallbladder and common bile duct stones
|
Gurusamy, Kurinchi
|
|
2012
|
|
1 |
p. 15-29
|
artikel
|
| 120 |
Is There Broad-Based Support in High-Income Countries for COVID-19 Vaccine Donation? Evidence from Seven Countries
|
Roope, Laurence S. J.
|
|
|
|
1 |
p. 55-65
|
artikel
|
| 121 |
Is the societal approach wide enough to include relatives?
|
Davidson, Thomas
|
|
2010
|
|
1 |
p. 25-35
|
artikel
|
| 122 |
Key performance indicators for the implementation of social health insurance
|
Carrin, Guy
|
|
2005
|
|
1 |
p. 15-22
|
artikel
|
| 123 |
Kinky Thresholds Revisited: Opportunity Costs Differ in the NE and SW Quadrants
|
Eckermann, Simon
|
|
2014
|
|
1 |
p. 7-13
|
artikel
|
| 124 |
Lessons from Game Theory about Healthcare System Price Inflation
|
Agee, Mark D.
|
|
2012
|
|
1 |
p. 45-51
|
artikel
|
| 125 |
Making Good Decisions in Healthcare with Multi-Criteria Decision Analysis: The Use, Current Research and Future Development of MCDA
|
Mühlbacher, Axel C.
|
|
2015
|
|
1 |
p. 29-40
|
artikel
|
| 126 |
Medicare coverage and reimbursement of outpatient prescription drugs in the US
|
Forrest, Sharon
|
|
2005
|
|
1 |
p. 9-14
|
artikel
|
| 127 |
Methodological aspects in the assessment of treatment effects in observational health outcomes studies
|
Haro, Josep Maria
|
|
2006
|
|
1 |
p. 11-25
|
artikel
|
| 128 |
Methods for Economic Evaluations of Novel Oral Anticoagulants in Patients with Atrial Fibrillation: A Systematic Review
|
Li, Yan
|
|
|
|
1 |
p. 33-48
|
artikel
|
| 129 |
Migraine-Related Healthcare Resource Use and Costs for Subjects Prescribed Fixed-Dose Combination Sumatriptan/Naproxen Sodium vs. Single-Entity Oral Triptans in a Managed Care Population in the USA
|
Runken, M. Chris
|
|
2014
|
|
1 |
p. 109-120
|
artikel
|
| 130 |
Modelling Informal Carers’ Health-Related Quality of Life: Challenges for Economic Evaluation
|
Pennington, Becky
|
|
|
|
1 |
p. 9-16
|
artikel
|
| 131 |
Multiple Criteria Decision Analysis in Health Technology Assessment for Drugs: Just Another Illusion?
|
Garattini, Livio
|
|
2017
|
|
1 |
p. 1-4
|
artikel
|
| 132 |
Ongoing pharmaceutical reforms in France
|
Sermet, Catherine
|
|
2010
|
|
1 |
p. 7-24
|
artikel
|
| 133 |
Oral therapies for the treatment of pulmonary arterial hypertension
|
Dranitsaris, George
|
|
2009
|
|
1 |
p. 43-59
|
artikel
|
| 134 |
Oral therapies for the treatment of pulmonary arterial hypertension: a population-based cost-minimization analysis
|
Lefebvre, Marie-Claude
|
|
2010
|
|
1 |
p. 69-71
|
artikel
|
| 135 |
Panobinostat Plus Bortezomib Versus Lenalidomide in Patients with Relapsed and/or Refractory Multiple Myeloma: A Matching-Adjusted Indirect Treatment Comparison of Survival Outcomes using Patient-level Data
|
Majer, Istvan
|
|
2016
|
|
1 |
p. 45-55
|
artikel
|
| 136 |
Peristeen Transanal Irrigation System to Manage Bowel Dysfunction: A NICE Medical Technology Guidance
|
Dale, Megan
|
|
2018
|
|
1 |
p. 25-34
|
artikel
|
| 137 |
Pipeline™ Embolization Device for the Treatment of Complex Intracranial Aneurysms
|
Withers, Kathleen
|
|
2013
|
|
1 |
p. 5-13
|
artikel
|
| 138 |
Private Health Insurance Incentives in Australia: In Search of Cost-Effective Adjustments
|
Sowa, P. Marcin
|
|
2017
|
|
1 |
p. 31-41
|
artikel
|
| 139 |
Promoting Antibacterial Drug Development: Select Policies and Challenges
|
Sertkaya, Aylin
|
|
2016
|
|
1 |
p. 113-118
|
artikel
|
| 140 |
Propensity-Score Matching in Economic Analyses: Comparison with Regression Models, Instrumental Variables, Residual Inclusion, Differences-in-Differences, and Decomposition Methods
|
Crown, William H.
|
|
2014
|
|
1 |
p. 7-18
|
artikel
|
| 141 |
Quality of Health Economic Evaluations in Mainland China: A Comparison of Peer-Reviewed Articles in Chinese and in English
|
Cheng, Jiehua
|
|
|
|
1 |
p. 35-54
|
artikel
|
| 142 |
Recycling blood
|
Crotty, Bernard
|
|
2006
|
|
1 |
p. 5-10
|
artikel
|
| 143 |
Reliability and Validity of the Contingent Valuation Method for Estimating Willingness to Pay: A Case of In Vitro Fertilisation
|
Settumba, Stella Nalukwago
|
|
2018
|
|
1 |
p. 103-110
|
artikel
|
| 144 |
Remember the MaineRx
|
Kemp, Robert
|
|
2014
|
|
1 |
p. 1-5
|
artikel
|
| 145 |
Road safety and accident prevention
|
Tay, Richard
|
|
2004
|
|
1 |
p. 3
|
artikel
|
| 146 |
Scale Effects and Expected Savings from Consolidation Policies of Italian Local Healthcare Authorities
|
Di Novi, Cinzia
|
|
2017
|
|
1 |
p. 107-122
|
artikel
|
| 147 |
Self-reported effectiveness of double-fine zones as a speed control measure
|
Jones, Barnie
|
|
2004
|
|
1 |
p. 17-28
|
artikel
|
| 148 |
Sherlock 3CG® Tip Confirmation System for Placement of Peripherally Inserted Central Catheters: A NICE Medical Technology Guidance
|
Dale, Megan
|
|
2015
|
|
1 |
p. 41-49
|
artikel
|
| 149 |
Societal Cost of Racial Pneumococcal Disease Disparities in US Adults Aged 50 Years or Older
|
Altawalbeh, Shoroq M.
|
|
|
|
1 |
p. 61-71
|
artikel
|
| 150 |
Standardized Questionnaire for the Measurement, Valuation, and Estimation of Costs of Informal Care Based on the Opportunity Cost and Proxy Good Method
|
Landfeldt, Erik
|
|
2018
|
|
1 |
p. 15-24
|
artikel
|
| 151 |
Strategies for Avoiding Neglect of Opportunity Costs by Decision-Makers
|
Karnon, Jonathan
|
|
|
|
1 |
p. 9-11
|
artikel
|
| 152 |
Systematic Overuse of Healthcare Services: A Conceptual Model
|
Nassery, Najlla
|
|
2014
|
|
1 |
p. 1-6
|
artikel
|
| 153 |
Systematic Review and Critique of Methods for Economic Evaluation of Digital Mental Health Interventions
|
Jankovic, Dina
|
|
|
|
1 |
p. 17-27
|
artikel
|
| 154 |
Systematic Review of Health State Utility Values Used in European Pharmacoeconomic Evaluations for Chronic Hepatitis C: Impact on Cost-Effectiveness Results
|
Han, Ru
|
|
|
|
1 |
p. 29-44
|
artikel
|
| 155 |
Tackling alcohol misuse
|
Ludbrook, Anne
|
|
2012
|
|
1 |
p. 51-63
|
artikel
|
| 156 |
The authors’ reply
|
Dranitsaris, George
|
|
2010
|
|
1 |
p. 71-73
|
artikel
|
| 157 |
The Chinese healthcare system
|
Hougaard, Jens Leth
|
|
2011
|
|
1 |
p. 1-13
|
artikel
|
| 158 |
The Cost Effectiveness of Implantable Cardioverter Defibrillators: A Systematic Review of Economic Evaluations
|
Gialama, Fotini
|
|
2013
|
|
1 |
p. 41-49
|
artikel
|
| 159 |
The Cost Effectiveness of Maintenance Schedules Following Pulmonary Rehabilitation in Patients with Chronic Obstructive Pulmonary Disease: An Economic Evaluation Alongside a Randomised Controlled Trial
|
Burns, Darren K.
|
|
2015
|
|
1 |
p. 105-115
|
artikel
|
| 160 |
The Cost-Effectiveness of Oral Nutrition Supplementation for Malnourished Older Hospital Patients
|
Zhong, Yue
|
|
2016
|
|
1 |
p. 75-83
|
artikel
|
| 161 |
The Economic Burden of Chronic Obstructive Pulmonary Disease in Greece
|
Kourlaba, Georgia
|
|
2018
|
|
1 |
p. 111-121
|
artikel
|
| 162 |
The Economic Evaluation of Medical Devices
|
Kirisits, Andreas
|
|
2013
|
|
1 |
p. 15-26
|
artikel
|
| 163 |
The Economic Evaluation of Medical Devices
|
Kirisits, Andreas
|
|
|
|
1 |
p. 15-26
|
artikel
|
| 164 |
The efficiency of a volumetric alcohol tax in Australia
|
Byrnes, Joshua
|
|
2012
|
|
1 |
p. 37-49
|
artikel
|
| 165 |
The End of the International Reference Pricing System?
|
Persson, Ulf
|
|
2015
|
|
1 |
p. 1-8
|
artikel
|
| 166 |
The Generic Drug Industry Embraces a Faster, Cheaper Pathway for Challenging Patents
|
Darrow, Jonathan J.
|
|
2018
|
|
1 |
p. 47-54
|
artikel
|
| 167 |
The impact of CT colonography for colorectal cancer screening on the UK NHS
|
Sweet, Alison
|
|
2011
|
|
1 |
p. 51-64
|
artikel
|
| 168 |
The impact of physician payment methods on raising the efficiency of the healthcare system
|
Simoens, Steven
|
|
2004
|
|
1 |
p. 39-46
|
artikel
|
| 169 |
The Inflation Reduction Act: Hope for Prescription Drug Prices in the USA
|
Allen, Lindsay
|
|
|
|
1 |
p. 5-7
|
artikel
|
| 170 |
The lifetime cost of hepatocellular carcinoma
|
Lang, Hui-Chu
|
|
2008
|
|
1 |
p. 55-65
|
artikel
|
| 171 |
The relationship between ex ante mortality risk and end-of-life medical costs
|
Howard, David H.
|
|
2006
|
|
1 |
p. 37-44
|
artikel
|
| 172 |
The reliability of willingness to pay for changes in health status
|
Smith, Richard D.
|
|
2004
|
|
1 |
p. 35-38
|
artikel
|
| 173 |
The role of health economics in alcohol policy
|
Doran, Christopher M.
|
|
2012
|
|
1 |
p. 33-35
|
artikel
|
| 174 |
The Use of Surrogate and Patient-Relevant Endpoints in Outcomes-Based Market Access Agreements
|
Toumi, Mondher
|
|
2016
|
|
1 |
p. 5-11
|
artikel
|
| 175 |
The value of life and accident costing
|
Mohd Fauzi, Mohd Y.
|
|
2004
|
|
1 |
p. 5-8
|
artikel
|
| 176 |
Towards a Broader Assessment of Value in Vaccines: The BRAVE Way Forward
|
Bell, Eleanor
|
|
|
|
1 |
p. 105-117
|
artikel
|
| 177 |
Towards a Transparent, Credible, Evidence-Based Decision-Making Process of New Drug Listing on the Hong Kong Hospital Authority Drug Formulary: Challenges and Suggestions
|
Wong, Carlos King Ho
|
|
2017
|
|
1 |
p. 5-14
|
artikel
|
| 178 |
Trends and Factors Associated with Hospitalization Costs for Inflammatory Bowel Disease in the United States
|
Xu, Fang
|
|
2018
|
|
1 |
p. 77-91
|
artikel
|
| 179 |
Triangulating health expenditure estimates from different data sources in developing countries
|
Lorenz, Christian
|
|
2012
|
|
1 |
p. 1-13
|
artikel
|
| 180 |
Untangling the debate surrounding strategies for achieving sustainable high coverage of insecticide-treated nets
|
Stevens, Warren
|
|
2005
|
|
1 |
p. 5-8
|
artikel
|
| 181 |
Use of Health Technology Assessment for the Continued Funding of Health Technologies: The Case of Immunoglobulins for the Management of Multifocal Motor Neuropathy
|
Vargas, Constanza
|
|
|
|
1 |
p. 73-84
|
artikel
|
| 182 |
Using a Formal Strategy of Priority Setting to Mitigate Austerity Effects Through Gains in Value: The Role of Program Budgeting and Marginal Analysis (PBMA) in the Brazilian Public Healthcare System
|
Seixas, Brayan V.
|
|
|
|
1 |
p. 9-15
|
artikel
|
| 183 |
Using economic analyses for local priority setting
|
Heller, Richard F.
|
|
2006
|
|
1 |
p. 45-54
|
artikel
|
| 184 |
Using Eye-Tracking Technology with Older People in Memory Clinics to Investigate the Impact of Mild Cognitive Impairment on Choices for EQ-5D-5L Health States Preferences
|
Wang, Kaiying
|
|
|
|
1 |
p. 111-121
|
artikel
|
| 185 |
Using value of information analysis to inform publicly funded research priorities
|
Ginnelly, Laura
|
|
2005
|
|
1 |
p. 37-46
|
artikel
|
| 186 |
Valuation of Costs in Health Economics During Financial and Economic Crises: A Case Study from Lebanon
|
Dahham, Jalal
|
|
|
|
1 |
p. 31-38
|
artikel
|
| 187 |
Valuing child health utility 9D health states with a young adolescent sample
|
Ratcliffe, Julie
|
|
2011
|
|
1 |
p. 15-27
|
artikel
|
| 188 |
Variation in Clinical Practice: A Priority Setting Approach to the Staged Funding of Quality Improvement
|
Karnon, Jonathan
|
|
2015
|
|
1 |
p. 21-27
|
artikel
|
| 189 |
VOLY: The Monetary Value of a Life-Year at the End of Patients’ Lives
|
Ribarić, Elizabeta
|
|
|
|
1 |
p. 97-106
|
artikel
|
| 190 |
Wealth status and risky sexual behaviour in Ghana and Kenya
|
Awusabo-Asare, Kofi
|
|
2008
|
|
1 |
p. 27-39
|
artikel
|
| 191 |
What Features of Fertility Treatment do Patients Value? Price Elasticity and Willingness-to-Pay Values from a Discrete Choice Experiment
|
Keller, Elena
|
|
|
|
1 |
p. 91-107
|
artikel
|
| 192 |
Why ‘Optimal’ Payment for Healthcare Providers Can Never be Optimal Under Community Rating
|
Zweifel, Peter
|
|
2015
|
|
1 |
p. 9-20
|
artikel
|
Tijdschrift beschrijving